[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Chin et al., 2000 - Google Patents

Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts

Chin et al., 2000

Document ID
7998251264172403153
Author
Chin G
Liu W
Steinbrech D
Hsu M
Levinson H
Longaker M
Publication year
Publication venue
Plastic and reconstructive surgery

External Links

Snippet

Keloids represent a dysregulated response to cutaneous wounding that results in disfiguring scars. Unique to humans, keloids are characterized by an accumulation of extracellular matrix components. The underlying molecular mechanisms of keloid pathogenesis …
Continue reading at journals.lww.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00—Cosmetic or similar toilet preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans

Similar Documents

Publication Publication Date Title
Chin et al. Cellular signaling by tyrosine phosphorylation in keloid and normal human dermal fibroblasts
ES2285195T3 (en) ERYTHROPOYETINE IN SUBPOLICITEMIC DOSE.
King Jr et al. Epidermal growth factor/transforming growth factor alpha receptors and psoriasis
US6821947B2 (en) Endorepellin: methods and compositions for inhibiting angiogenesis
DE69736129T2 (en) Methods and compositions for the treatment of neoplastic diseases
MacDonald et al. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3
JPH07179356A (en) Epitheliocyte growth promoter
US6194380B1 (en) Agents for promoting bone formation
Steplewski et al. Inhibition of collagen fibril formation
Luomanen et al. Distribution of tenascin in healing incision, excision and laser wounds
US6187822B1 (en) Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
JP2002542824A (en) Recombinant laminin 5
ES2978920T3 (en) Antifibrogenic compounds, methods and uses thereof
JP2000509978A (en) AL-2 neurotrophic factor
CA2318432C (en) The use of isolated domains of type iv collagen to modify cell and tissue interactions
Dubertret et al. Activities of human acidic fibroblast growth factor in an in vitro dermal equivalent model
CA2329160A1 (en) Wound treatment through inhibition of adenosine diphosphate ribosyl transferase
US6703363B1 (en) Recombinant laminin 5
WO1997004104A3 (en) Tumor type ii hexokinase transcription regulatory regions
CN108314727B (en) Membrane type metalloprotease inhibiting protein and its use
Luomanen et al. Fibronectins in healing incision, excision and laser wounds
CN108949730A (en) A kind of preparation method and applications recombinating allosteric clostridiopetidase A
Lam et al. Synthetic peptides cytomodulin-1 (CM-1) and cytomodulin-2 (CM-2) promote collagen synthesis and wound healing in vitro
KR100860081B1 (en) Pharmaceutical composition for regulating the degradation of HIF1-?
CA2274116C (en) Use, of an inhibitor of thioredoxin, for inhibiting tumor growth